Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 50 av 97 resultater
Tid
Selskap
Tittel
Sektor
Kategori
19 Dec 2024
17:58 CET
ONWARD MEDICAL
ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière destiné aux personnes atteintes de lésion chroniqu...
20101025 Health Services
-
19 Dec 2024
17:58 CET
ONWARD MEDICAL
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury
20101025 Health Services
-
12 Dec 2024
07:30 CET
ONWARD MEDICAL
ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability
20101025 Health Services
-
26 Nov 2024
07:30 CET
ONWARD MEDICAL
ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights
20101025 Health Services
-
19 Nov 2024
07:30 CET
ONWARD MEDICAL
ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke
20101025 Health Services
-
12 Nov 2024
07:30 CET
ONWARD MEDICAL
ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights
20101025 Health Services
-
31 Oct 2024
06:30 CET
ONWARD MEDICAL
ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024
20101025 Health Services
-
28 Oct 2024
17:45 CET
ONWARD MEDICAL
ONWARD® Medical Publishes Closing of Bookbuild Offering
20101025 Health Services
-
24 Oct 2024
17:45 CEST
ONWARD MEDICAL
ONWARD® Medical Publishes Prospectus for Listing of New Shares
20101025 Health Services
-
24 Oct 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical lève avec succès 50 millions d’euros dans le cadre d’une levée de fonds majorée avec le soutien d’Ottobock SE & Co. KGaA
20101025 Health Services
-
24 Oct 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA
20101025 Health Services
-
22 Oct 2024
20:21 CEST
ONWARD MEDICAL
ONWARD® Medical lance une augmentation de capital d’un montant d’environ 40 millions d’euros dont 22,5 millions d’engagement ferme de la part d’Ottobock SE & Co. KGaA
20101025 Health Services
-
22 Oct 2024
17:45 CEST
ONWARD MEDICAL
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA
20101025 Health Services
-
21 Oct 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman
20101025 Health Services
-
15 Oct 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec
20101025 Health Services
-
15 Oct 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology
20101025 Health Services
-
20 Sep 2024
19:45 CEST
ONWARD MEDICAL
ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
20101025 Health Services
-
19 Sep 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière
20101025 Health Services
-
19 Sep 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
20101025 Health Services
-
10 Sep 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
20101025 Health Services
-
03 Sep 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
20101025 Health Services
-
27 Aug 2024
18:53 CEST
ONWARD MEDICAL
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
20101025 Health Services
-
05 Aug 2024
23:47 CEST
ONWARD MEDICAL
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
20101025 Health Services
-
17 Jul 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Publishes Annual Sustainability Summary
20101025 Health Services
-
09 Jul 2024
19:18 CEST
ONWARD MEDICAL
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
20101025 Health Services
-
28 Jun 2024
23:53 CEST
ONWARD MEDICAL
ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
20101025 Health Services
-
26 Jun 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Announces Participation in Stifel European Healthcare Summit
20101025 Health Services
-
18 Jun 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference
20101025 Health Services
-
13 Jun 2024
23:36 CEST
ONWARD MEDICAL
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
20101025 Health Services
-
24 May 2024
03:19 CEST
ONWARD MEDICAL
ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des Jahres
20101025 Health Services
-
24 May 2024
03:19 CEST
ONWARD MEDICAL
ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écoulée
20101025 Health Services
-
23 May 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
20101025 Health Services
-
22 May 2024
19:13 CEST
ONWARD MEDICAL
ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine
20101025 Health Services
-
22 May 2024
19:13 CEST
ONWARD MEDICAL
ONWARD® Medical veranstaltet Webcast zu Einzelheiten der Up-LIFT-Studie und der aktuellen Veröffentlichung in Nature Medicine
20101025 Health Services
-
21 May 2024
23:53 CEST
ONWARD MEDICAL
Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® Therapy
20101025 Health Services
-
21 May 2024
23:53 CEST
ONWARD MEDICAL
Nature Medicine hebt signifikante Verbesserung der Hand- und Armfunktion nach einer Rückenmarksverletzung durch die ONWARD® ARC-EX® Therapie hervor
20101025 Health Services
-
21 May 2024
18:25 CEST
ONWARD MEDICAL
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication
20101025 Health Services
-
20 May 2024
17:35 CEST
ONWARD MEDICAL
Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy
20101025 Health Services
-
16 May 2024
00:43 CEST
ONWARD MEDICAL
ONWARD® Medical plant Webcast zur Vorstellung des Geschäftsverlaufs im 1. Quartal 2024
20101025 Health Services
-
16 May 2024
00:43 CEST
ONWARD MEDICAL
ONWARD® Medical organise un webinaire pour présenter l’état des lieux de ses activités du premier trimestre 2024
20101025 Health Services
-
15 May 2024
00:21 CEST
ONWARD MEDICAL
ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update
20101025 Health Services
-
03 May 2024
03:31 CEST
ONWARD MEDICAL
Avis de convocation à l’assemblée générale 2024 des actionnaires ONWARD® et propositions de résolutions
20101025 Health Services
-
02 May 2024
07:00 CEST
ONWARD MEDICAL
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
20101025 Health Services
-
26 Apr 2024
15:17 CEST
ONWARD MEDICAL
ONWARD® Medical annonce ses résultats financiers et opérationnels pour l’exercice 2023 et partage les faits qui ont marqué l’exercice 2024 à ce jour
20101025 Health Services
-
25 Apr 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
20101025 Health Services
-
11 Apr 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
20101025 Health Services
-
09 Apr 2024
07:00 CEST
ONWARD MEDICAL
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
20101025 Health Services
-
02 Apr 2024
07:30 CEST
ONWARD MEDICAL
ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
20101025 Health Services
-
25 Mar 2024
17:40 CET
ONWARD MEDICAL
ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France
20101025 Health Services
-
21 Mar 2024
18:26 CET
ONWARD MEDICAL
ONWARD® Medical Publishes Prospectus for Listing of New Shares
20101025 Health Services
-
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
1
2
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
DSP
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva